273 related articles for article (PubMed ID: 32662050)
1. Robotic multivisceral pelvic resection: experience from an exenteration unit.
Smith N; Murphy DG; Lawrentschuk N; McCormick J; Heriot A; Warrier S; Lynch AC
Tech Coloproctol; 2020 Nov; 24(11):1145-1153. PubMed ID: 32662050
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration.
Saqib SU; Raza MZ; Twigg J; Altan O; Bajwa AA
Langenbecks Arch Surg; 2023 Dec; 409(1):9. PubMed ID: 38102305
[TBL] [Abstract][Full Text] [Related]
3. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
Williams M; Perera M; Nouhaud FX; Coughlin G
Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
Platt E; Dovell G; Smolarek S
Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and safety of minimally invasive multivisceral resection for T4b rectal cancer: A 9-year review.
Chan KS; Liu B; Tan MNA; How KY; Wong KY
World J Gastrointest Surg; 2024 Mar; 16(3):777-789. PubMed ID: 38577068
[TBL] [Abstract][Full Text] [Related]
6. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
[No Abstract] [Full Text] [Related]
7. Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer.
Turner GA; Harris CA; Eglinton TW; Wakeman CJ; Kueppers F; Dixon L; Dobbs BR; Frizelle FA
ANZ J Surg; 2016; 86(1-2):54-8. PubMed ID: 25113257
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study of using basement membrane biological products in pelvic floor reconstruction during pelvic exenteration].
Chen GL; Wang YL; Zhang X; Tao Y; Sun YH; Chen JN; Wang SQ; Su N; Wang ZG; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):268-276. PubMed ID: 36925127
[No Abstract] [Full Text] [Related]
9. Minimally Invasive Surgery for Pelvic Exenteration in Primary Colorectal Cancer.
Kumar NA; Sasi SP; Shinde RS; Verma K; Sugoor P; Desouza A; Engineer R; Saklani A
JSLS; 2020; 24(3):. PubMed ID: 32714002
[TBL] [Abstract][Full Text] [Related]
10. Robotic-assisted multivisceral resection for rectal cancer: short-term outcomes at a single center.
Hino H; Yamaguchi T; Kinugasa Y; Shiomi A; Kagawa H; Yamakawa Y; Numata M; Furutani A; Yamaoka Y; Manabe S; Suzuki T; Kato S
Tech Coloproctol; 2017 Nov; 21(11):879-886. PubMed ID: 29134385
[TBL] [Abstract][Full Text] [Related]
11. Salvage robotic anterior pelvic exenteration for cervical cancer: technique and feasibility.
Jain V; Debnath S; Rawal S
J Robot Surg; 2021 Dec; 15(6):945-953. PubMed ID: 33515209
[TBL] [Abstract][Full Text] [Related]
12. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases.
Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ
Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722
[TBL] [Abstract][Full Text] [Related]
13. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
[TBL] [Abstract][Full Text] [Related]
14. Robotic radical anterior pelvic exenteration: the UCI experience.
Kaufmann OG; Young JL; Sountoulides P; Kaplan AG; Dash A; Ornstein DK
Minim Invasive Ther Allied Technol; 2011 Jul; 20(4):240-6. PubMed ID: 21142832
[TBL] [Abstract][Full Text] [Related]
15. Minimally invasive versus open pelvic exenterations for rectal cancer: a comparative analysis of perioperative and 3-year oncological outcomes.
Kazi M; Kumar NAN; Rohila J; Sukumar V; Engineer R; Ankathi S; Desouza A; Saklani A
BJS Open; 2021 Sep; 5(5):. PubMed ID: 34518872
[TBL] [Abstract][Full Text] [Related]
16. Robotic coloanal anastomosis with or without intersphincteric resection for low rectal cancer: starting with the perianal approach followed by robotic procedure.
Kang J; Hur H; Min BS; Lee KY; Kim NK
Ann Surg Oncol; 2012 Jan; 19(1):154-5. PubMed ID: 21822556
[TBL] [Abstract][Full Text] [Related]
17. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.
Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O
J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132
[TBL] [Abstract][Full Text] [Related]
18. Robotic beyond total mesorectal excision surgery for primary and recurrent pelvic malignancy: Feasibility and short-term outcomes.
Larach JT; Flynn J; Fernando D; Mohan H; Rajkomar A; Waters PS; Kong J; McCormick JJ; Heriot AG; Warrier SK
Colorectal Dis; 2022 Jul; 24(7):821-827. PubMed ID: 35373888
[TBL] [Abstract][Full Text] [Related]
19. Minimally invasive pelvic exenteration for gynaecological malignancy: A single-centre case series and review of the literature.
Karkia R; Tailor A; Ellis P; Madhuri T; Scala A; Read J; Perry M; Patil K; Blackburn A; Butler-Manuel S; Chatterjee J
Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():56-61. PubMed ID: 35584578
[TBL] [Abstract][Full Text] [Related]
20. Survival and morbidity outcomes after pelvic exenteration for pelvic sarcoma: an institutional series.
Lee PJ; Meshkat B; Sasidharan P; Zahid A; Coker DJ; Solomon MJ
ANZ J Surg; 2022 May; 92(5):1038-1043. PubMed ID: 34661958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
